Clinical Research Directory
Browse clinical research sites, groups, and studies.
Obesity Management for Kidney TRANSPLANTation: OK-TRANSPLANT 2
Sponsor: Western University, Canada
Summary
OK-TRANSPLANT 2 is a vanguard study for a large randomized, pragmatic, open-label trial. We will randomize participants with obesity, high-risk CKD/dialysis who are hoping for lose weight for the purpose of kidney transplant. Subjects will either be enrolled on a virtual weight management program or continue their usual care.
Official title: Obesity Management for Kidney TRANSPLANTation: a Vanguard Study for an Innovative Randomized Controlled Trial, Embedded in Routine Care (OK-TRANSPLANT 2)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2024-09-26
Completion Date
2026-02
Last Updated
2026-02-20
Healthy Volunteers
No
Conditions
Interventions
Semaglutide
Maximum tolerated dose of semaglutide subcutaneously once weekly. Maximum dose of 2.0 mg.
Virtual Weight Management Coaching
Virtual meeting with intervention coach once every 4 weeks for 6 months, where the coach will discuss the goals and progress with participant, nutritional advice, exercise advice, and motivational support.
Locations (1)
London Health Sciences Centre
London, Ontario, Canada